Clostridium difficile infection epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Clostridium difficile}}
{{Siren|Clostridium difficile infection}}
{{Clostridium difficile infection}}
{{CMG}}; {{AE}} {{YD}}
{{CMG}}; {{AE}} {{YD}}
==Overview==
==Overview==
The incidence of ''C. difficile'' infection is estimated to be 20 per 100,000 person-years. In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations. Although patients of all age groups may develop ''C. difficile'' infection, elderly patients > 65 years may have up to eight-fold increased risk of developing ''C. difficile'' infection compared with younger patients. Whites and female patients are more predisposed to develop ''C. difficile'' infections. Although ''C. difficile'' is abundantly reported in Europe and the United States, the infection is a global burden.
The incidence of ''C. difficile'' infection is estimated to be 140 per 100,000 individuals. In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations. Although patients of all age groups may develop ''C. difficile'' infection, elderly patients > 65 years may have up to eight-fold increased risk of developing ''C. difficile'' infection compared with younger patients. Whites and female patients are more predisposed to develop ''C. difficile'' infections. Although ''C. difficile'' is abundantly reported in Europe and the United States, the infection is a global burden.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of ''C. difficile'' infection is estimated to be 20 per 100,000 person-years and approximately 1,500 per 100,000 hospital discharges.<ref name="pmid25714160">{{cite journal| author=Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR et al.| title=Burden of Clostridium difficile infection in the United States. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 9 | pages= 825-34 | pmid=25714160 | doi=10.1056/NEJMoa1408913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25714160  }} </ref>
*The incidence of ''C. difficile'' infection is estimated to be 140 per 100,000 individuals and approximately 1,500 per 100,000 hospital discharges.<ref name="pmid25714160">{{cite journal| author=Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR et al.| title=Burden of Clostridium difficile infection in the United States. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 9 | pages= 825-34 | pmid=25714160 | doi=10.1056/NEJMoa1408913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25714160  }} </ref>
 
In the U.S. [[Veterans Affairs]] system, approximately 0.5% of admissions have c diff<ref name="pmid26864803">{{cite journal| author=Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA| title=Effect of a Clostridium difficile Infection Prevention Initiative in Veterans Affairs Acute Care Facilities. | journal=Infect Control Hosp Epidemiol | year= 2016 | volume= 37 | issue= 6 | pages= 720-2 | pmid=26864803 | doi=10.1017/ice.2016.27 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26864803  }} </ref><ref name="pmid31708000">{{cite journal| author=Sumon ZE, Lesse AJ, Sellick JA, Tetewsky S, Mergenhagen KA| title=Temporal trends of inpatient C. difficile infections within the Veterans Health Administration hospitals: An analysis of the effect of molecular testing, time to testing, and mandatory reporting. | journal=Infect Control Hosp Epidemiol | year= 2020 | volume= 41 | issue= 1 | pages= 44-51 | pmid=31708000 | doi=10.1017/ice.2019.281 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31708000  }} </ref>.


===Age===
===Age===
Line 16: Line 19:


===Race===
===Race===
*White individuals are more predisposed to the development of ''C. difficile'' infection.<ref name="pmid25714160">{{cite journal| author=Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR et al.| title=Burden of Clostridium difficile infection in the United States. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 9 | pages= 825-34 | pmid=25714160 | doi=10.1056/NEJMoa1408913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25714160  }} </ref>
*Caucasian individuals are more likely to develop ''C. difficile'' infection.<ref name="pmid25714160">{{cite journal| author=Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR et al.| title=Burden of Clostridium difficile infection in the United States. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 9 | pages= 825-34 | pmid=25714160 | doi=10.1056/NEJMoa1408913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25714160  }} </ref>


===Developed Countries===
===Developed Countries===
Line 36: Line 39:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Infectious disease]]
 
[[Category:Bacterial diseases]]
[[Category:Bacterial diseases]]

Latest revision as of 02:29, 13 July 2020

Resident
Survival
Guide

C. difficile Infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Clostridium difficile infectionfrom other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Abdominal X Ray

Abdominal CT Scan

Other Imaging Findings

Biopsy

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Clostridium difficile infection epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clostridium difficile infection epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clostridium difficile infection epidemiology and demographics

CDC on Clostridium difficile infection epidemiology and demographics

Clostridium difficile infection epidemiology and demographics in the news

Blogs on Clostridium difficile infection epidemiology and demographics

Directions to Hospitals Treating Clostridium difficile

Risk calculators and risk factors for Clostridium difficile infection epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.

Overview

The incidence of C. difficile infection is estimated to be 140 per 100,000 individuals. In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations. Although patients of all age groups may develop C. difficile infection, elderly patients > 65 years may have up to eight-fold increased risk of developing C. difficile infection compared with younger patients. Whites and female patients are more predisposed to develop C. difficile infections. Although C. difficile is abundantly reported in Europe and the United States, the infection is a global burden.

Epidemiology and Demographics

Incidence

  • The incidence of C. difficile infection is estimated to be 140 per 100,000 individuals and approximately 1,500 per 100,000 hospital discharges.[1]

In the U.S. Veterans Affairs system, approximately 0.5% of admissions have c diff[2][3].

Age

  • Patients of all age groups may develop C. difficile infection.
  • Elderly patients > 65 years may have up to eight-fold increased risk of developing C. difficile infection compared with younger patients.[1]

Gender

  • There is a slight female predisposition to the development of C. difficile infection with a female to male ratio of 1.26.[1]

Race

  • Caucasian individuals are more likely to develop C. difficile infection.[1]

Developed Countries

  • The estimated number of incident C. difficile infection in USA is estimated to be approximately range between approximately 397,000 and 508,500.[1]
  • In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations.[1]
  • In USA, the NAP1 C. difficile strain is more common in healthcare settings than in community settings.
  • In 2011, approximately 29,000 deaths have been attributed to C. difficile infection in USA.[1]
  • Several C. difficile outbreaks have been reported in Canada, USA, and Europe.

Developing Countries

  • Although C. difficile is abundantly reported in Europe and the United States, the infection is a global burden.
  • The burden of C. difficile in developing countries is difficult to estimate due to scarcity of available data.

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR; et al. (2015). "Burden of Clostridium difficile infection in the United States". N Engl J Med. 372 (9): 825–34. doi:10.1056/NEJMoa1408913. PMID 25714160.
  2. Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA (2016). "Effect of a Clostridium difficile Infection Prevention Initiative in Veterans Affairs Acute Care Facilities". Infect Control Hosp Epidemiol. 37 (6): 720–2. doi:10.1017/ice.2016.27. PMID 26864803.
  3. Sumon ZE, Lesse AJ, Sellick JA, Tetewsky S, Mergenhagen KA (2020). "Temporal trends of inpatient C. difficile infections within the Veterans Health Administration hospitals: An analysis of the effect of molecular testing, time to testing, and mandatory reporting". Infect Control Hosp Epidemiol. 41 (1): 44–51. doi:10.1017/ice.2019.281. PMID 31708000.